Cryoport Inc (Cryoport) is a provider of temperature-controlled supply chain solutions. The company provides products and services designed to mitigate risks and ensure the safe and reliable storage and delivery of critical therapies and other high-value biologic materials. The company serves the biopharmaceutical, animal health, and reproductive medicine markets. It's business portfolio includes a range of products and services such as Cryoport Express Shippers, Cryoport ELITE Shippers, and the Cryoport Express Cryogenic HV3 Shipping System. The company also offers the Smartpak II Condition Monitoring System and Tec4Med's SmartHub and CryoBeacon for comprehensive supply chain visibility. It provides biostorage and bioservices through its CRYOGENE and Cryoport Systems units, offering secure storage and management of biological specimens.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

CryoPort develops and maintains protection on the proprietary aspects of its platform of technologies by relying on a combination of patents, copyrights, trademarks, trade secret laws, and confidentiality agreements to protect its intellectual property rights. The company files patent applications to protect innovations arising from its research, development, and design. As of December 31, 2025, CryoPort owned approximately 74 issued patents and had 110 pending patent applications throughout the world. The company's patents generally protect certain aspects of its products and related technology.